Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.

Authors:
Eunsil Choi Chad J Michalski Seung Ho Choo Gyoung Nyoun Kim Elizabeth Banasikowska Sangkyun Lee Kunyu Wu Hwa-Yong An Anthony Mills Stefan Schneider U Fritz Bredeek Daniel R Coulston Shilei Ding Andrés Finzi Meijuan Tian Katja Klein Eric J Arts Jamie F S Mann Yong Gao C Yong Kang

Retrovirology 2016 Nov 28;13(1):82. Epub 2016 Nov 28.

Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, The University of Western Ontario, 1400 Western Road, London, ON, N6G 2V4, Canada.

Background: Vaccination with inactivated (killed) whole-virus particles has been used to prevent a wide range of viral diseases. However, for an HIV vaccine this approach has been largely negated due to inherent safety concerns, despite the ability of killed whole-virus vaccines to generate a strong, predominantly antibody-mediated immune response in vivo. HIV-1 Clade B NL4-3 was genetically modified by deleting the nef and vpu genes and substituting the coding sequence for the Env signal peptide with that of honeybee melittin signal peptide to produce a less virulent and more replication efficient virus. This genetically modified virus (gmHIV-1) was inactivated and formulated as a killed whole-HIV vaccine, and then used for a Phase I human clinical trial (Trial Registration: Clinical Trials NCT01546818). The gmHIV-1 was propagated in the A3.01 human T cell line followed by virus purification and inactivation with aldrithiol-2 and γ-irradiation. Thirty-three HIV-1 positive volunteers receiving cART were recruited for this observer-blinded, placebo-controlled Phase I human clinical trial to assess the safety and immunogenicity.

Results: Genetically modified and killed whole-HIV-1 vaccine, SAV001, was well tolerated with no serious adverse events. HIV-1-specific PCR showed neither evidence of vaccine virus replication in the vaccine virus-infected human T lymphocytes in vitro nor in the participating volunteers receiving SAV001 vaccine. Furthermore, SAV001 with adjuvant significantly increased the pre-existing antibody response to HIV-1 proteins. Antibodies in the plasma of vaccinees were also found to recognize HIV-1 envelope protein on the surface of infected cells as well as showing an enhancement of broadly neutralizing antibodies inhibiting tier I and II of HIV-1 B, D, and A subtypes.

Conclusion: The killed whole-HIV vaccine, SAV001, is safe and triggers anti-HIV immune responses. It remains to be determined through an appropriate trial whether this immune response prevents HIV infection.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12977-016-0317-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126836PMC
November 2016

Publication Analysis

Top Keywords

genetically modified
12
vaccine sav001
12
human clinical
12
clinical trial
12
phase human
12
killed whole-hiv
8
immune response
8
signal peptide
8
whole-hiv-1 vaccine
8
killed whole-virus
8
volunteers receiving
8
whole-hiv vaccine
8
vaccine
8
killed whole-hiv-1
8
killed
6
hiv-1
5
trial
5
hiv-1 positive
4
observer-blinded placebo-controlled
4
placebo-controlled phase
4

Keyword Occurance

Similar Publications

Droplet digital PCR or quantitative PCR for in-depth genomic and functional validation of genetically altered rodents.

Authors:
Loic Lindner Pauline Cayrou Thomas W Rosahl Esther Heather Zhou Marie-Christine Birling Yann Herault Guillaume Pavlovic

Methods 2021 Apr 7. Epub 2021 Apr 7.

PHENOMIN-Institut Clinique de la Souris, CELPHEDIA, CNRS, INSERM, Université de Strasbourg, Illkirch-Graffenstaden, Strasbourg, 67404, France. Electronic address:

Gene targeting and additive (random) transgenesis have proven to be powerful technologies with which to decipher the mammalian genome. With the advent of CRISPR/Cas9 genome editing, the ability to inactivate or modify the function of a gene has become even more accessible. However, the impact of each generated modification may be different from what was initially desired. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Challenges of Automation and Scale: Bioinformatics and the Evaluation of Proteins to Support Genetically Modified Product Safety Assessments.

Authors:
Colton Kessenich Andre Silvanovich

J Invertebr Pathol 2021 Apr 7:107587. Epub 2021 Apr 7.

Bayer Crop Science, 700 Chesterfield Pkwy West, Chesterfield, MO 63017.

Bioinformatic analyses of protein sequences play an important role in the discovery and subsequent safety assessment of insect control proteins in Genetically Modified (GM) crops. Due to the rapid adoption of high-throughput sequencing methods over the last decade, the number of protein sequences in GenBank and other public databases has increased dramatically. Many of these protein sequences are the product of whole genome sequencing efforts, coupled with automated protein sequence prediction and annotation pipelines. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Generation of Murine Bone Marrow and Fetal Liver Chimeras.

Authors:
Stéphane Chappaz Tahnee L Saunders Benjamin T Kile

Curr Protoc 2021 Apr;1(4):e79

Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.

The generation of radiation chimeras allows researchers to substitute the hematopoietic system of a mouse with that of one or more donors. A suspension of hematopoietic stem cells (HSCs) is prepared from the bone marrow (BM) or the fetal liver (FL) of a donor mouse and adoptively transferred into an irradiated recipient. Within days, the donor's HSCs will engraft, and their progeny will quickly replace the blood cells of the recipient. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Establishment of bovine expanded potential stem cells.

Authors:
Lixia Zhao Xuefei Gao Yuxuan Zheng Zixin Wang Gaoping Zhao Jie Ren Jia Zhang Jian Wu Baojiang Wu Yanglin Chen Wei Sun Yunxia Li Jie Su Yulin Ding Yuan Gao Moning Liu Xiaochun Bai Liangzhong Sun Guifang Cao Fuchou Tang Siqin Bao Pentao Liu Xihe Li

Proc Natl Acad Sci U S A 2021 Apr;118(15)

The State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Inner Mongolia University, 010070 Hohhot, China;

Embryonic stem cells (ESCs) and induced pluripotent stem cells have the potential to differentiate to all cell types of an adult individual and are useful for studying development and for translational research. However, extrapolation of mouse and human ESC knowledge to deriving stable ESC lines of domestic ungulates and large livestock species has been challenging. In contrast to ESCs that are usually established from the blastocyst, mouse expanded potential stem cells (EPSCs) are derived from four-cell and eight-cell embryos. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap